Skip Navigation
Explore our COVID-19 Resources and Updates
CHS blue logo square
 
 
Home > Our Work > All Publications > 2021

Publications

Our publications keep professionals working across the public, private, and academic sectors informed on the most important developments and issues in health security and biosecurity.

Find an article or report by keywords:

 
 
Find an article or report or see all by area, author, or year:

Title:

Pediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know

Authors:
William J. Moss; Lawrence O. Gostin; Jennifer B. Nuzzo
Date posted:
November 05, 2021
Publication type:
Article
Publication:
JAMA 2021
DOI:
10.1001/jama.2021.20734
See also:
Introduction:
The US Food and Drug Administration (FDA) granted Emergency Use Authorization for Pfizer-BioNTech’s mRNA COVID-19 vaccine (BNT162b2) for children 5 to 11 years of age on October 29, 2021. The Centers for Disease Control and Prevention recommended use of the vaccine among children in this age group on November 2, 2021. Approximately 28 million children are now eligible for vaccination, with only those younger than 5 years remaining excluded from vaccine eligibility. The benefits of pediatric COVID-19 vaccines are clear. Vaccinations protect children, decrease spread to families and communities, and ensure educational continuity. What do parents, practitioners, and policy makers need to know about pediatric COVID-19 vaccines?

 

 

Our Mission

To protect people’s health from epidemics and disasters and ensure that communities are resilient to major challenges.